The HypoAna trial reported an ARR of 0.51 events per person-year for treatment with insulin analogs compared to human insulins, whereas Hermansen et al. found no statistically significant difference in the rate of severe hypoglycemia between the two treatment groups. Here, INS is linked to Hypoglycemia.